{"Name":"PrognosDx Health","perma":"prognosdx-health","BasicInfo":{"funded":"2008-01-01","isClosed":false,"closed":null,"short":"PrognosDx Health develops and commercializes epigenetic tests based on histone modification patterns."},"FundingRounds":[{"funding_type":"debt_financing","series":null,"announcedDate":"2011-05-17","moneyRaised":10000}],"Acquisitions":[],"AcquiredBy":null,"IPO":null,"Investments":[],"Products":[],"ProductsPermas":[],"CurrentTeam":[{"title":"Chief Executive Officer & Board Member","started":null,"ended":null,"firstName":"Joseph","lastName":"J. Vallner"},{"title":"Founder & Executive Chairman","started":null,"ended":null,"firstName":"Kamran","lastName":"Tahamtanzadeh"},{"title":"COO, EVP","started":null,"ended":null,"firstName":"Babak","lastName":"N. Alizadeh"}],"PastTeam":[]}
